Clinical Trial Update: Evaluate the Safety, Tolerability, Pharmacokinetic Profile, Efficacy of Bl-M11D1 [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the safety, tolerability, pharmacokinetics, and preliminary efficacy of Bl-M11D1 in patients with relapsed/refractory acute my…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• BL-M11D1

Snippet

Sponsor: SystImmune Inc. | Conditions: Relapsed/Refractory Acute Myeloid Leukemia | Phase 1 | Status: RECRUITING